CHCT Community Healthcare Trust Inc
Real Estate Investment Trusts · NYSE · SEC CIK 1631569 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY5.5%
TTM net income YoY399.0%
TTM EPS YoY287.2%
Revenue 3-yr CAGR5.0%
Net income 3-yr CAGR38.8%
Margins
Gross margin—
Operating margin—
Net margin17.8%
FCF margin31.9%
EBITDA margin—
Returns
ROE5.3%
ROA2.3%
ROIC (approx.)—
Asset turnover0.13x
Leverage & solvency
Liabilities / assets58.7%
Debt / equity1.35x
Current ratio—
Interest coverage—
Cash quality & payout
Operating cash flow / net income2.71x
Accruals ratio-3.8%
Payout ratio225.2%
Capex / revenue16.2%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 | FY20232023-12-31 | FY20222022-12-31 | FY20212021-12-31 |
|---|---|---|---|---|---|
| Income statement | |||||
| Revenue | $121.19M | $115.79M | $112.84M | $97.68M | $90.58M |
| SG&A expense | $25.09M | $19.06M | $27.34M | $14.84M | $12.11M |
| Interest expense | $26.98M | $23.71M | $17.79M | $11.87M | $10.54M |
| Pretax income | — | — | — | — | $32.91M |
| Income tax | $177,000 | $145,000 | $412,000 | $138,000 | $296,000 |
| Net income | $5.10M | -$3.18M | $7.71M | $22.02M | $22.49M |
| EPS (basic) | 0.08 | -0.23 | 0.20 | 0.81 | 0.87 |
| EPS (diluted) | 0.08 | -0.23 | 0.20 | 0.81 | 0.87 |
| Dividends declared per share | 1.89 | 1.84 | 1.80 | 1.76 | 1.73 |
| Weighted avg. shares (diluted) | 26.86M | 26.53M | 25.20M | 23.63M | 23.26M |
| Banking | |||||
| Net interest income | -$156,000 | $1.22M | $4.16M | — | — |
| Balance sheet | |||||
| Cash & equivalents | $3.34M | $4.38M | $4.63M | $12.07M | $2.87M |
| Total assets | $990.76M | $992.56M | $945.41M | $876.42M | $754.23M |
| Long-term debt | $532.20M | $485.95M | $403.26M | $353.00M | $265.62M |
| Total debt | $532.20M | $485.95M | $403.26M | $353.00M | $265.62M |
| Total liabilities | $561.37M | $516.60M | $432.16M | $379.61M | $292.12M |
| Shareholders' equity | $429.39M | $475.96M | $513.26M | $496.81M | $462.11M |
| Net debt | $528.86M | $481.57M | $398.62M | $340.93M | $262.76M |
| Shares outstanding | 28.47M | 28.24M | 27.61M | 25.90M | 24.98M |
| Cash flow statement | |||||
| Operating cash flow | $56.43M | $58.88M | $61.38M | $60.28M | $56.35M |
| Capital expenditure | $20.52M | $24.64M | $18.98M | $10.38M | $7.22M |
| Free cash flow | $35.91M | $34.24M | $42.40M | $49.90M | $49.13M |
| Investing cash flow | -$47.70M | -$92.66M | -$113.67M | -$113.77M | -$104.43M |
| Financing cash flow | -$9.78M | $33.53M | $44.86M | $62.69M | $48.05M |
| Depreciation & amortization | $43.54M | $42.78M | $39.69M | $32.34M | $30.40M |
| Stock-based compensation | $10.30M | $9.99M | $8.17M | $9.41M | $7.16M |
| Dividends paid | $53.67M | $51.70M | $48.06M | $44.48M | $42.41M |
Free plan shows the latest 5 periods; Pro shows all 11 🔒
· Financial companies (banks, insurers, …) usually do not report gross profit or operating income; bank revenue is net revenue (net interest income + noninterest income), smaller than "gross interest income + noninterest income".
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.